Effects of cannabidiol on behavioral seizures caused by convulsant drugs or current in mice
References (27)
- et al.
Effect of cannabinoids on neurotransmitter uptake, ATPase activity and morphology of mouse brain synaptosomes
Biochem. Pharmacol.
(1977) - et al.
Pretreatment with delta-1-tetrahydrpcannabinol and psychoactive drugs: Effects on uptake of biogenic amines and on behavior
European J. Pharmacol.
(1979) - et al.
Gabergic mediation in the inhibition of hippocampal acetylcholine turnover rate elicited by delta-9-tetrahydrocannabinol
Neuropharmacology
(1979) - et al.
Amino acid content of epileptogenic human brain: focal versus surrounding regions
Brain Res.
(1972) - et al.
Cannabinoids: Influence on neurotransmitter uptake in rat brain synaptosomes
J. Pharmacol. Exp. Ther.
(1975) - et al.
Metabolic and psychophysiologic studies of cannabidiol-hexobarbital interaction
Clin. Pharmacol. Ther.
(1980) - et al.
Cannabidiol and Cannabis sativa extract protect mice and rats against convulsive agents
J. Pharm. Pharmacol.
(1973) - et al.
Anticonvulsant activity of four oxygenated cannabidiol derivatives
Res. Comm. Chem. Path. Pharmacol.
(1975) - et al.
Manipulation of cerebral monoamines in the treatment of human epilepsy: A pilot study
Epilepsia
(1978) - et al.
Antiepileptic potential of cannabidiol analogs
J. Clin. Pharmacol.
(1981)
Chronic administration of cannabidiol to healthy volunteers and epileptic patients
Pharmacology
(1980)
BMD Biomedical Computer Programs
(1977)
Probit Analysis
(1962)
Cited by (112)
The perceived effects of cannabis products in the management of seizures in CDKL5 Deficiency Disorder
2021, Epilepsy and Behavior
Copyright © 1982 Published by Elsevier B.V.